Related Experiment Videos
Fungal infections in transplant recipients
Abstract:
Fungi are ubiquitous and the respiratory tract is exposed to aerosolized spores of both fungi that are "pathogenic" even in the normal host, such as Cryptococus neoformans, and those that are "opportunistic", such as Candida and Aspergillus species, among others. Although these latter species may occasionally form fungal balls or induce allergic phenomena in the normal host, they produce more invasive diseases in immunosuppressed patients. Among these diseases, pseudomembranous aspergillosis has recently been described. The diagnostic approach to these entities, and, in particular, the thin dividing line between colonization and infection are addressed, along with the diagnostic value of the various procedures. New prophylactic regimens are reviewed such as the possibility of using amphotericin aerosols in combination with systemic azole administration. The authors would emphasize the importance of restoring lung defences by not only decreasing immunosuppressive regimens but also considering the use of newly available recombinant cytokines such as growth factors, to reduce neutropenia, for instance, in addition to antifungal drugs when infection is diagnosed. However, immunomodulation procedures are far from being well established.
Insights
This study examines fungal respiratory infections, differentiating between colonization and invasive disease in immunocompromised patients. It reviews diagnostic methods and new treatments, including antifungal drugs and immunomodulation, to improve patient outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pulmonology
Background:
- Fungal spores are ubiquitous, exposing the respiratory tract to pathogenic and opportunistic fungi.
- Opportunistic fungi like Aspergillus and Candida cause invasive diseases, particularly in immunosuppressed individuals.
- Pseudomembranous aspergillosis is a recently described invasive fungal disease.
Purpose of the Study:
- To address the diagnostic challenges in differentiating fungal colonization from infection.
- To evaluate the diagnostic value of various procedures for fungal respiratory diseases.
- To review novel prophylactic and therapeutic strategies for invasive fungal infections.
Main Methods:
- Review of diagnostic approaches for fungal respiratory infections.
- Analysis of current and emerging prophylactic regimens.
- Discussion of immunomodulatory strategies to enhance host defenses.
Main Results:
- The distinction between fungal colonization and invasive infection is critical for appropriate management.
- New prophylactic strategies include aerosolized amphotericin B with systemic azoles.
- Restoring lung defenses involves reducing immunosuppression and considering recombinant cytokines.
Conclusions:
- Effective management of fungal respiratory infections requires accurate diagnosis and tailored treatment.
- Combination therapies and host defense restoration are key to improving outcomes in immunosuppressed patients.
- Immunomodulation shows promise but requires further research and clinical validation.